Skip to content
lifestyle.militaryparenting.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals’ Latest NETHERTON NOW Video Details the Life of a Family Living with Netherton Syndrome
November 6, 2026
Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results
November 5, 2026
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
October 29, 2026
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
October 20, 2026
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
October 14, 2026
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
October 6, 2026
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
September 22, 2026
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
September 10, 2026
CORRECTION — Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
September 8, 2026
Quoin Pharmaceuticals: QRX003 Receives FDA Rare Pediatric Disease Designation
September 8, 2026
1
2
3
Next Page
→